Form 8-K - Current report:
SEC Accession No. 0001104659-25-002846
Filing Date
2025-01-13
Accepted
2025-01-13 07:05:11
Documents
15
Period of Report
2025-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253044d1_8k.htm   iXBRL 8-K 27472
2 EXHIBIT 99.1 tm253044d1_ex99-1.htm EX-99.1 16680
6 GRAPHIC tm253044d1_ex99-1img01.jpg GRAPHIC 3964
  Complete submission text file 0001104659-25-002846.txt   227684

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ntra-20250112.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntra-20250112_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntra-20250112_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT tm253044d1_8k_htm.xml XML 3683
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37478 | Film No.: 25524756
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)